Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Zepsun (donafenib)
i
Other names:
CM4307, CM-4307, CM 4307
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Twitter
Trials
Company:
Suzhou Zelgen
Drug class:
Multi-tyrosine kinase inhibitor, cRAF inhibitor
Related drugs:
‹
sorafenib (166)
anlotinib (108)
ponatinib (93)
pazopanib (72)
gilteritinib (67)
cabozantinib tablet (65)
regorafenib (59)
midostaurin (41)
cabozantinib capsule (24)
TPX-0005 (23)
nintedanib (17)
MGCD516 (5)
AEE788 (4)
APG-2449 (4)
TT-00420 (4)
SHR 1020 (3)
AMG 706 (2)
HA121-28 (1)
SY-707 (1)
CT053PTSA (1)
encorafenib (60)
VS-6766 (27)
ERAS-254 (4)
RAF709 (3)
sorafenib (166)
anlotinib (108)
ponatinib (93)
pazopanib (72)
gilteritinib (67)
cabozantinib tablet (65)
regorafenib (59)
midostaurin (41)
cabozantinib capsule (24)
TPX-0005 (23)
nintedanib (17)
MGCD516 (5)
AEE788 (4)
APG-2449 (4)
TT-00420 (4)
SHR 1020 (3)
AMG 706 (2)
HA121-28 (1)
SY-707 (1)
CT053PTSA (1)
encorafenib (60)
VS-6766 (27)
ERAS-254 (4)
RAF709 (3)
›
Associations
(1)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
KRAS G12C
Non Small Cell Lung Cancer
KRAS G12C
Non Small Cell Lung Cancer
ZG19018 + donafenib
Sensitive: D – Preclinical
AACR 2023 - 1 week (New D)
ZG19018 + donafenib
Sensitive
:
D
AACR 2023 - 1wk
ZG19018 + donafenib
Sensitive: D – Preclinical
AACR 2023 - 1 week
ZG19018 + donafenib
Sensitive
:
D
AACR 2023 - 1 week - (New D)
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login